Aspirin or P2Y12i monotherapy for secondary prevention in patients with CAD?
This video was recorded during the ESC Congress 2022 in Barcelona, Spain.
Marco Valgimigli, MD, PhD - Cardiocentro Ticino Foundation, Lugano in Switzerland.
This recording was developed under auspices of EPCCS. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of EPCCS.